Totally agree. That is why a positive 28 readout is so critical, it will confirm that CYP has a commercial product that is safe. Hypothetically, if CYP decides to be a raw-product supplier to Bio-pharma, it would not have to fund any further FDA trials. There are many options open to the company to have early revenue streams. Fuji is just one of many revenue models.
- Forums
- ASX - By Stock
- CYP
- Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD
Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD, page-21
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.91M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 21.0¢ | $1K | 4.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 0.205 |
4 | 133803 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 15055 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 9000 | 1 |
0.220 | 135000 | 2 |
0.225 | 30000 | 1 |
0.230 | 161397 | 3 |
0.240 | 10000 | 1 |
Last trade - 11.02am 26/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online